LSP floats new life sciences fund
This article was originally published in Scrip
Life Science Partners has established a new fund to invest in publicly quoted life science companies, raising initially just over €35 million in an initial public offering on the NYSE Euronext Amsterdam. LSP Life Sciences Fund NV will be managed by the same team that has been responsible, on behalf of LSP Advisory BV, for advising on investments in small to medium-sized publicly listed life science companies made under an strategic advisory agreement with APG Investments in 2008. Since that time, LSP's investments in publicly listed stocks has generated a return of more than 150%.